These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 29459716)
1. Common Deregulation of Seven Biological Processes by MicroRNAs in Gastrointestinal Cancers. Zhang L; Zhang Y; Wong SH; Law PTY; Zhao S; Yu J; Chan MTV; Wu WKK Sci Rep; 2018 Feb; 8(1):3287. PubMed ID: 29459716 [TBL] [Abstract][Full Text] [Related]
2. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer. Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644 [TBL] [Abstract][Full Text] [Related]
3. A MicroRNA Signature in Gestational Diabetes Mellitus Associated with Risk of Macrosomia. Li J; Song L; Zhou L; Wu J; Sheng C; Chen H; Liu Y; Gao S; Huang W Cell Physiol Biochem; 2015; 37(1):243-52. PubMed ID: 26302821 [TBL] [Abstract][Full Text] [Related]
4. A Novel Role for MiR-520a-3p in Regulating EGFR Expression in Colorectal Cancer. Zhang R; Liu R; Liu C; Niu Y; Zhang J; Guo B; Zhang CY; Li J; Yang J; Chen X Cell Physiol Biochem; 2017; 42(4):1559-1574. PubMed ID: 28738328 [TBL] [Abstract][Full Text] [Related]
5. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma. Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation. Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971 [TBL] [Abstract][Full Text] [Related]
7. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status. Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor. Liu X; Li G Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer. Coarfa C; Fiskus W; Eedunuri VK; Rajapakshe K; Foley C; Chew SA; Shah SS; Geng C; Shou J; Mohamed JS; O'Malley BW; Mitsiades N Oncogene; 2016 May; 35(18):2345-56. PubMed ID: 26364608 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of miRNAs in enterovirus 71-infected cells. Xun M; Ma CF; Du QL; Ji YH; Xu JR Virol J; 2015 Apr; 12():56. PubMed ID: 25889836 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor. Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1. Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337 [TBL] [Abstract][Full Text] [Related]
13. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. Zhang C; Zhang CD; Ma MH; Dai DQ World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201 [TBL] [Abstract][Full Text] [Related]
14. miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer. Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Luo S; Xie J Oncol Rep; 2017 Jan; 37(1):123-130. PubMed ID: 27878272 [TBL] [Abstract][Full Text] [Related]
15. Autophagy-related microRNAs: Possible regulatory roles and therapeutic potential in and gastrointestinal cancers. Pourhanifeh MH; Vosough M; Mahjoubin-Tehran M; Hashemipour M; Nejati M; Abbasi-Kolli M; Sahebkar A; Mirzaei H Pharmacol Res; 2020 Nov; 161():105133. PubMed ID: 32822869 [TBL] [Abstract][Full Text] [Related]
16. Analysis of targets and functions coregulated by microRNAs. Chen SJ; Chen HC Methods Mol Biol; 2011; 676():225-41. PubMed ID: 20931401 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma. Pereira TDSF; Brito JAR; GuimarĂ£es ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608 [TBL] [Abstract][Full Text] [Related]
18. MiR-200 Regulates Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer via EGF/EGFR Signaling. Xue L; Su D; Li D; Gao W; Yuan R; Pang W Cell Biochem Biophys; 2015 May; 72(1):185-90. PubMed ID: 25542369 [TBL] [Abstract][Full Text] [Related]
19. Altered expression profile of micrornas in gastric stromal tumor. Xiao J; Wang QX; Zhu YQ J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):842-850. PubMed ID: 26670434 [TBL] [Abstract][Full Text] [Related]
20. Genomic sequence analysis of EGFR regulation by microRNAs in lung cancer. Chan LW; Wang FF; Cho WC Curr Top Med Chem; 2012; 12(8):920-6. PubMed ID: 22352917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]